American Heart Association – 2022 (Chicago)

LBCT Presentations

Michelle O’Donoghue – Reduction of Lipoprotein(a) With Small Interfering RNA – Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Featured Science

Prakriti Gaba – Association Between Achieved LDL-Cholesterol and Long-term Cardiovascular and Safety Outcomes – An Analysis of the FOURIER and FOURIER-OLE Studies

Other Presentations

David Berg – Serial Assessment of Cardiac Biomarkers and Risk of Cardiovascular Death or Hospitalization for Heart Failure in DECLARE-TIMI 58

Brian Bergmark – Risk Prediction with the Anatomic SYNTAX Score in Patients with Left Main Coronary Artery Disease Undergoing PCI or CABG

Sarah Donnelly-Interhospital Differences in the Use of Critical Care Therapies in CICUs and Its Association With In-Hospital Mortality-Insights from CCCTN

Nicholas Marston – Cardiovascular Benefit of Lowering LDL-C Below 40 mg per dl

Filipe Moura – Type 2 Diabetes Mellitus Polygenic Score Predicts New Onset Diabetes in Patients With Established Atherosclerotic Cardiovascular Disease-A FOURIER Sub-Study

Siddharth Patel – Safety and Efficacy of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin Across Body Mass Index and Body Weight – Insights from COMBINE-AF

Meir Schechter – The Effect of Dapagliflozin on Hospital Admissions in Patients with Type 2 Diabetes-Post Hoc Analysis of the DECLARE-TIMI 58 trial

Aeron Small – Development of a Novel Polygenic Risk Score to Predict Risk of Aortic Stenosis Events

Anubodh Varshney – End-Organ Dysfunction Differs in Patients with Heart Failure-Related vs. Acute-Myocardial Infarction-Related Cardiogenic Shock